Matches in SemOpenAlex for { <https://semopenalex.org/work/W1570263903> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W1570263903 endingPage "46.35" @default.
- W1570263903 startingPage "46.35" @default.
- W1570263903 abstract "Abstract ALT-801 is a fusion protein between interleukin-2 and a T cell receptor domain capable of recognizing tumors presenting human p53 peptide (aa264-272)/HLA-A*0201 complexes. Previously, we have reported that ALT-801 exhibits significantly better antitumor activity than IL-2 in various mouse tumor models. Substantial efficacy in human malignancies has been observed. In this study, we found that intravenous administration of ALT-801 significantly prolonged survival of C57BL/6 mice bearing MB49luc orthotopic muscle invasive and superficial bladder cancer when compared with PBS treatment. The ALT-801-treated mice also survived rechallenge with MB49luc tumor cells, indicating long-lasting immune response and long-term memory. Additionally, ALT-801 exhibited potent antitumor activity against human bladder cancer HLA-A*0201+/p53+ UMUC-14 and HLA-A*0201-negative/p53+ KU7 xenografts in nude mice, suggesting its targeting activity is not required for efficacy. ALT-801 combined with gemcitabine showed better antitumor effects and less toxicity than gemcitabine + cisplatin (GC) chemotherapy in the UMUC-14 and KU7 xenograft models, despite the different sensitivity of these tumor cells to GC. We’ll discuss the mechanisms of action of ALT-801 in this report. Based on these preclinical findings, we have already initiated a clinical study of ALT-801 on human metastatic bladder cancer." @default.
- W1570263903 created "2016-06-24" @default.
- W1570263903 creator A5011687963 @default.
- W1570263903 creator A5020186418 @default.
- W1570263903 creator A5059906816 @default.
- W1570263903 creator A5063368856 @default.
- W1570263903 creator A5069160791 @default.
- W1570263903 creator A5073822069 @default.
- W1570263903 date "2012-05-01" @default.
- W1570263903 modified "2023-10-18" @default.
- W1570263903 title "Intravenous administration of a novel IL-2 fusion protein, ALT-801, inhibits bladder cancer in mouse models (46.35)" @default.
- W1570263903 doi "https://doi.org/10.4049/jimmunol.188.supp.46.35" @default.
- W1570263903 hasPublicationYear "2012" @default.
- W1570263903 type Work @default.
- W1570263903 sameAs 1570263903 @default.
- W1570263903 citedByCount "1" @default.
- W1570263903 countsByYear W15702639032015 @default.
- W1570263903 crossrefType "journal-article" @default.
- W1570263903 hasAuthorship W1570263903A5011687963 @default.
- W1570263903 hasAuthorship W1570263903A5020186418 @default.
- W1570263903 hasAuthorship W1570263903A5059906816 @default.
- W1570263903 hasAuthorship W1570263903A5063368856 @default.
- W1570263903 hasAuthorship W1570263903A5069160791 @default.
- W1570263903 hasAuthorship W1570263903A5073822069 @default.
- W1570263903 hasConcept C121608353 @default.
- W1570263903 hasConcept C126322002 @default.
- W1570263903 hasConcept C2776694085 @default.
- W1570263903 hasConcept C2778239845 @default.
- W1570263903 hasConcept C2780258809 @default.
- W1570263903 hasConcept C2780352672 @default.
- W1570263903 hasConcept C502942594 @default.
- W1570263903 hasConcept C71924100 @default.
- W1570263903 hasConcept C98274493 @default.
- W1570263903 hasConceptScore W1570263903C121608353 @default.
- W1570263903 hasConceptScore W1570263903C126322002 @default.
- W1570263903 hasConceptScore W1570263903C2776694085 @default.
- W1570263903 hasConceptScore W1570263903C2778239845 @default.
- W1570263903 hasConceptScore W1570263903C2780258809 @default.
- W1570263903 hasConceptScore W1570263903C2780352672 @default.
- W1570263903 hasConceptScore W1570263903C502942594 @default.
- W1570263903 hasConceptScore W1570263903C71924100 @default.
- W1570263903 hasConceptScore W1570263903C98274493 @default.
- W1570263903 hasIssue "1_Supplement" @default.
- W1570263903 hasLocation W15702639031 @default.
- W1570263903 hasOpenAccess W1570263903 @default.
- W1570263903 hasPrimaryLocation W15702639031 @default.
- W1570263903 hasRelatedWork W2041115418 @default.
- W1570263903 hasRelatedWork W2100029565 @default.
- W1570263903 hasRelatedWork W2118212877 @default.
- W1570263903 hasRelatedWork W2361287035 @default.
- W1570263903 hasRelatedWork W2374795505 @default.
- W1570263903 hasRelatedWork W2381460883 @default.
- W1570263903 hasRelatedWork W2429664059 @default.
- W1570263903 hasRelatedWork W2512894035 @default.
- W1570263903 hasRelatedWork W2892336168 @default.
- W1570263903 hasRelatedWork W3031949156 @default.
- W1570263903 hasVolume "188" @default.
- W1570263903 isParatext "false" @default.
- W1570263903 isRetracted "false" @default.
- W1570263903 magId "1570263903" @default.
- W1570263903 workType "article" @default.